Test Price
2,800 AED✅ Home Collection Available
REEP2 (SPG72) Gene Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
Executive Summary
A single-gene, next-generation sequencing investigation for Hereditary Spastic Paraplegia Type 72 — designed for precise diagnosis, family planning, and proactive neurological care. 99.9% diagnostic sensitivity achieved through ISO 9001:2015 accredited NGS workflow. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. Direct billing verification via WhatsApp at +971545488731. Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The REEP2 (SPG72) Gene Genetic Test identifies pathogenic variants in the REEP2 gene responsible for autosomal recessive Hereditary Spastic Paraplegia type 72. This single‑gene assay uses next‑generation sequencing to deliver a definitive molecular diagnosis, guiding neurologists, medical geneticists, and genetic counselors in treatment stratification and family at‑risk assessment.
Methodology Comparison
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | Single‑gene NGS, full coding region ±10 bp | Whole‑exome sequencing (lower coverage) |
| Method | Next‑Generation Sequencing (Illumina® DRAGEN) | Sanger sequencing (limited throughput) |
| Turnaround | 3–4 weeks | 6–8 weeks for exome re‑analysis |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
“A positive REEP2 mutation firmly anchors a clinical diagnosis of SPG72, but genetic findings must always be correlated with a comprehensive neurological examination and electrophysiology. This test cannot replace expert clinical judgment or medication adherence. If you have concerns about hereditary spastic paraplegia, please consult your neurologist before stopping any prescribed treatment.”
Medication Advisory
Do not discontinue any prescribed medications without consulting your physician. Genetic test results alone are insufficient to determine therapy changes. Always correlate with clinical evaluation.
Exclusion Criteria & Emergency Red Flags
- Sample collected in heparin tube (invalid for DNA extraction).
- Incomplete clinical history or lack of written informed consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency: If the patient develops acute limb weakness, loss of bladder control, or sudden visual changes, seek immediate emergency care — do not wait for genetic results.
Patient FAQ & Clinical Guidance
1. What does the REEP2 (SPG72) test detect, and who should consider it?
This NGS assay definitively identifies disease‑causing mutations in the REEP2 gene, confirming a diagnosis of hereditary spastic paraplegia type 72 for individuals with progressive lower‑limb stiffness and a suggestive family history.
2. How is the sample collected and what is the processing time?
A trained phlebotomist collects a small blood sample at your home, work, or clinic through our VIP Mobile Phlebotomy service (8 AM–11 PM). The DNA is then sequenced over 3–4 weeks in our ISO‑certified laboratory with temperature‑controlled cold chain transport.
3. Will my insurance cover this test and how do I verify?
Many UAE insurers include genetic testing for hereditary neurological conditions. We provide direct billing verification within minutes via WhatsApp at +971545488731. Pre‑authorization may be required.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and stored in secure UAE‑based servers. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds DHA Facility License Number 1143 and is ISO 9001:2015 certified (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | REEP2 (SPG72) Gene Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), Extracted DNA (≥1 µg), or Dried Blood Spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) – full coding region ±10 bp |
| ICD-10-CM Code | G11.4 (Hereditary spastic paraplegia) |
| LOINC Code | 55233-1 (Genetic analysis of a specific gene mutation) |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians